Trial Profile
Three year study investigating the effect of fingolimod on cognitive function in patients with relapsing-remitting multiple sclerosis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Dec 2016
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 28 Dec 2016 New trial record